CRAI(CRAI)
CRAI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $801M | $838M |
| Low | $799M | $822M |
| High | $804M | $857M |
| EBITDA Avg | $111M | $116M |
| Low | $110M | $113M |
| High | $111M | $118M |
| EBIT Avg | $80M | $84M |
| Low | $80M | $82M |
| High | $81M | $86M |
| Net Income Avg | $58M | $62M |
| Low | $55M | $61M |
| High | $61M | $69M |
| EPS Avg | $8.60 | $9.63 |
| Low | $8.20 | $9.15 |
| High | $9.06 | $10.34 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $198M | $203M | $201M | $205M | $207M | $209M |
| Low | $197M | $201M | $200M | $203M | $205M | $207M |
| High | $201M | $206M | $204M | $207M | $209M | $211M |
| EBITDA Avg | $27M | $28M | $28M | $28M | $29M | $29M |
| Low | $27M | $28M | $28M | $28M | $28M | $29M |
| High | $28M | $28M | $28M | $29M | $29M | $29M |
| EBIT Avg | $20M | $20M | $20M | $21M | $21M | $21M |
| Low | $20M | $20M | $20M | $20M | $21M | $21M |
| High | $20M | $21M | $20M | $21M | $21M | $21M |
| Net Income Avg | $14M | $15M | $16M | $16M | $16M | $17M |
| Low | $14M | $15M | $15M | $16M | $16M | $17M |
| High | $15M | $15M | $16M | $17M | $17M | $17M |
| EPS Avg | $2.19 | $2.27 | $2.37 | $2.48 | $2.48 | $2.55 |
| Low | $2.09 | $2.24 | $2.34 | $2.45 | $2.46 | $2.52 |
| High | $2.33 | $2.31 | $2.41 | $2.52 | $2.53 | $2.59 |
| Analysts (Rev / EPS) | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 2 |